Bristol-Myers Squibb CompanyBMYNYSE
Loading
Debt Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.64% |
| Q3 2025 | 0.22% |
| Q2 2025 | -0.61% |
| Q1 2025 | 0.08% |
| Q4 2024 | -0.39% |
| Q3 2024 | -4.82% |
| Q2 2024 | -5.93% |
| Q1 2024 | 38.46% |
| Q4 2023 | 5.60% |
| Q3 2023 | 0.21% |
| Q2 2023 | -0.47% |
| Q1 2023 | -3.31% |
| Q4 2022 | 1.51% |
| Q3 2022 | -6.81% |
| Q2 2022 | -6.42% |
| Q1 2022 | 0.88% |
| Q4 2021 | -0.54% |
| Q3 2021 | -0.97% |
| Q2 2021 | -2.06% |
| Q1 2021 | -8.52% |
| Q4 2020 | 12.81% |
| Q3 2020 | -3.58% |
| Q2 2020 | -0.04% |
| Q1 2020 | -0.02% |
| Q4 2019 | 89.96% |
| Q3 2019 | -0.08% |
| Q2 2019 | 313.56% |
| Q1 2019 | -17.59% |
| Q4 2018 | 0.57% |
| Q3 2018 | -1.08% |
| Q2 2018 | -4.06% |
| Q1 2018 | -3.29% |
| Q4 2017 | -5.70% |
| Q3 2017 | 2.75% |
| Q2 2017 | -2.57% |
| Q1 2017 | 25.73% |
| Q4 2016 | -1.73% |
| Q3 2016 | 1.34% |
| Q2 2016 | 0.55% |
| Q1 2016 | 0.15% |